Skip to main content
SpringerLink
Log in
Book cover

Studies on Competition and Antitrust Issues in the Pharmaceutical Industry

  • Book
  • © 2017

Overview

Authors:
  1. Ann-Kathrin Lehnhausen

    1. VWl I – Industrieökonomie, Wettbewerbspolitik- und Regulierung, JL Universität, Gießen, Germany

    View author publications

    You can also search for this author in PubMed   Google Scholar

  • Overview on pharmaceutical Research and Development
  • Includes supplementary material: sn.pub/extras

Part of the book series: BestMasters (BEST)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 79.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (5 chapters)

  1. Front Matter

    Pages I-XIV
    Download chapter PDF

  2. Introduction

    • Ann-Kathrin Lehnhausen
    Pages 1-3

  3. The Pharmaceutical Industry

    • Ann-Kathrin Lehnhausen
    Pages 5-21

  4. Anticompetitive actions taken by one firm only

    • Ann-Kathrin Lehnhausen
    Pages 23-57

  5. Interactions Between Two or More Firms

    • Ann-Kathrin Lehnhausen
    Pages 59-68

  6. Conclusion

    • Ann-Kathrin Lehnhausen
    Pages 69-70

  7. Back Matter

    Pages 71-85
    Download chapter PDF
Back to top

Keywords

About this book

This publication examines how drug originator manufacturers manage to shield their products from competition. It characterizes the pharmaceutical industry in detail and analyzes actions that violate antitrust laws in the USA and/or the European Union. The publication examines, for example, pay-for-delay strategies, market foreclosure, resale price maintenance, but also mergers and acquisitions, while taking into account market specificities such as the unique research and development process. The study explains why drug prices sometimes remain at elevated levels even after the drug’s patent protection has expired. Knowing the characteristics of such anticompetitive strategies helps customers such as health insurance companies to develop effective counter-strategies.

Authors and Affiliations

  • VWl I – Industrieökonomie, Wettbewerbspolitik- und Regulierung, JL Universität, Gießen, Germany

    Ann-Kathrin Lehnhausen

About the author

Ann-Kathrin Lehnhausen, M.Sc. in Business Administration and M.A. in Economics, worked at Justus-Liebig-University Giessen as teaching asssistant during her studies. After her graduation she started working as junior sales manager, responsible for API Exports, at a pharmaceutical company, where she combines her interest in economics with her interest in the pharmaceutical market.

Bibliographic Information

  • Book Title: Studies on Competition and Antitrust Issues in the Pharmaceutical Industry

  • Authors: Ann-Kathrin Lehnhausen

  • Series Title: BestMasters

  • DOI: https://doi.org/10.1007/978-3-658-16551-2

  • Publisher: Springer Gabler Wiesbaden

  • eBook Packages: Business and Management, Business and Management (R0)

  • Copyright Information: Springer Fachmedien Wiesbaden GmbH 2017

  • Softcover ISBN: 978-3-658-16550-5Published: 22 November 2016

  • eBook ISBN: 978-3-658-16551-2Published: 14 November 2016

  • Series ISSN: 2625-3577

  • Series E-ISSN: 2625-3615

  • Edition Number: 1

  • Number of Pages: XIV, 85

  • Number of Illustrations: 3 b/w illustrations

  • Topics: Innovation/Technology Management, Health Economics, Economic Policy

Publish with us

Policies and ethics

Back to top

Search

Navigation